Biogen Immunology Strategy Comes Into Focus With $1B HI-Bio Acquisition
Biogen’s acquisition of Human Immunology Biosciences brings a drug candidate with potential applications in multiple immune-mediated disorders. The deal comes just prior to the scheduled presentation of clinical data in two of them.
Allying With Patients to Make Every Cure Possible
To win the battle against rare diseases, drug developers must work hand-in-hand with patients.
5 Things to Know About How NIH’s SEED Can Help Life Science Startups Grow
The NIH’s SEED office formed to help startups leverage government’s funding programs. Chris Sasiela, director of the SEED office, discussed these programs during the MedCity News INVEST Conference in Chicago.
4 Things Digital Health Investors Need To Get Off Their Chest
During a panel at MedCity News’ INVEST conference, venture capitalists shared some of their takes on today’s healthcare funding landscape — including their thoughts on AI and the industry’s slower investment pace.
Why Healthcare Data Is Vital for Employers
Employers need healthcare data in order to make decisions, but the data isn't always easy to get, experts said on a panel at MedCity INVEST.